http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009529054-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009529054-A |
| titleOfInvention | Use of pyrazolo [1,5A] pyrimidin-7-ylamine derivatives in the treatment of neurological disorders |
| abstract | The present invention relates to the use of the compounds of the invention comprising pyrazolo [1,5a] pyrimidin-7-ylamine compounds and salts thereof, and medicaments comprising the same in the treatment of Eph receptor related (eg nerve) injury and disorders Relates to the composition. The invention also relates to modulating cellular Eph receptor activity, stimulating nerve regeneration, and restoring neurodegeneration by administering to a cell or subject an effective amount of a compound of the invention. |
| priorityDate | 2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 678.